New liquid viagra versions put to the test against popular ED pills
NCT ID NCT07117383
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage study will compare how two new liquid forms of sildenafil (Hezkue and Hezkue Turbo) are absorbed in the body versus several commercial ED products like Viagra and chewable tablets. Seventy-two healthy men will take single doses after a meal, and researchers will measure drug levels and side effects like headache or dizziness. The goal is to see if the new formulations offer any differences in absorption or tolerability.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
sildenafil (the active ingredient in Viagra)
What this could lead to
If successful, this could show that Hezkue or Hezkue Turbo are absorbed differently than other sildenafil products, potentially offering a new option for erectile dysfunction.
What could go wrong
This is an early Phase 1 study in only 72 healthy men, not people with erectile dysfunction. It only measures absorption and short-term side effects, not whether the drugs actually work for ED.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ERECTILE DYSFUNCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aspargo Labs
New York, New York, 10004, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••